Radiotherapy Fraction in Limited-Stage Small Cell Lung Cancer in the Modern Era: A Systematic Review and Meta-Analysis of 8006 Reconstructed Individual Patient Data

SIMPLE SUMMARY: The optimal thoracic radiotherapy (TRT) dose and fractionation for limited-stage small cell lung cancer (LS-SCLC) remains debatable due to inconclusive evidence. With a comprehensive systematic review involving not only randomized controlled trials (RCTs) but real-world cohorts and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jingjing, Wu, Linfang, Hu, Chen, Bi, Nan, Wang, Luhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818135/
https://www.ncbi.nlm.nih.gov/pubmed/36612272
http://dx.doi.org/10.3390/cancers15010277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818135/
https://www.ncbi.nlm.nih.gov/pubmed/36612272
http://dx.doi.org/10.3390/cancers15010277

Ejemplares similares